|
UAF policy and related
procedures comply with the NIH Guidelines for Research Involving
Recombinant DNA Molecules, US laws and regulations regarding the possession,
use and transfer of Select Agents and Toxins, and appropriate professional
society guidelines.
All Registration Applications (rDNA or Infectious
Agent) must be submitted by a UAF person who meets the requirements to
be a Principal
Investigator (PI) on a funding proposal. The PI on a grant should
normally serve as the PI on the LBC Assurance; any exceptions must
be approved by the Office of Research Integrity.
Basic
information on Biosafety Levels and related precautions is available
in the readings suggested below or by contacting the UAF Biosafety Officer
(Tracey Martinson).
Recommended Readings
NIH
Guidelines for Research Involving Recombinant DNA Molecules.
Must be adhered to for all NIH funded research involving recombinant
DNA molecules.
The
1, 2, 3's of Biosafety Levels. Covers the basic requirements
for Biosafety Levels 1, 2 and 3. This presentation was written
by Jonathan Y. Richmond, Ph.D., Director,
Office of Health and Safety, Centers for Disease Control and Prevention
and is adapted from the
CDC/NIH 3rd edition of Biosafety in Microbiological and Biomedical
Laboratories (Link available below).
Biosafety
in Microbiological and BIomedical Laboratories. HHS Publication
No. (CDC) 93-8395. U.S. Department of Health and Human Services,
Public Health Service,Centers for Disease Control and Prevention
and National Institutes of Health, 3rd Edition March 1993. U.S.
GOVERNMENT PRINTING OFFICE WASHINGTON: 1993. This publication is
available in html format and provides excellent information on
Biosafety Levels 1-4 and specific guidance on biosafety precautions
for handling a variety of infectious agents.
|
